Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay.
This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG).
Company Details
- Employees
- 9
- Founded
- 2022
- Address
- 21, Rue Jean Rostand, Parc Orsay-Université,france
- Industry
- Biotechnology
- Website
- https://www.bbtx.fr
- Keywords
- Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, Drug.
- HQ
- Orsay, Île-de-France
Blue Bees Therapeutics Questions
Blue Bees Therapeutics's website is https://www.bbtx.fr
Blue Bees Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/blue-bees-therapeutics
Blue Bees Therapeutics has
9 employees.
View email and phone details for 9
employees at Blue Bees Therapeutics.
Blue Bees Therapeutics's industry is
Biotechnology
Blue Bees Therapeutics's top competitors are
Persea,
Xenothera,
React Therapeutics,
Meiragtx,
Apmonia Therapeutics,
Ervimmune,
Dolinnov,
Abbelight,
Gio Therapeutics,
Kadima Capital.
Blue Bees Therapeutics's categories are Biotechnology
Blue Bees Therapeutics's founding year is 2022
